4746
K. Kato et al. / Tetrahedron Letters 50 (2009) 4744–4746
O
Me2N
O
R
O
1) TiCl4 / Zn
Ph
Et
propiophenone
Ph
Et
O
R
O
R
2) NaOMe
4d
6d
R = HO(CH2)4
R = H :tamoxifen
26 % (2 steps)
R
O
R = BzO(CH2)4
R = OH :4-hydroxytamoxifen
R
Scheme 4. Synthetic approach to the new tamoxifen analogue.
S. Bioorg. Med. Chem. Lett. 2007, 17, 5586; (c) Álvarez, C.; Álvarez, R.; Corchete,
P.; López, J. L.; Pérez-Melero, C.; Peláez, R.; Medarde, M. Bioorg. Med. Chem.
2008, 16, 5952.
allenyl ketones 1a–k, some unidentified small spots were detected
from the reaction mixture by thin-layer chromatography.
To investigate the utility of the present reaction, a preliminary
study for the synthesis of a new tamoxifen analogue is shown in
Scheme 4. Tamoxifen (NolvadexÒ) is one of the most important che-
motherapeutic agents for the treatment of breast cancer. Its primary
metabolite, 4-hydroxytamoxifen has a greater affinity for the estro-
gen receptor than tamoxifen, and may contribute to the in vivo anti-
tumour activity.3 However, after a period of response, tamoxifen-
resistant tumours eventually develop, creating the need for new po-
tent non-toxic antiestrogens. Towards this aim, coupling of the dif-
uranylketone 4d with propiophenone using TiCl4/Zn in THF3e
followed by methanolysis afforded the tamoxifen analogue 6d in
26% yield.
5. (a) Handbook of Organopalladium Chemistry for Organic Synthesis; Negishi, E.,
Ed.; Wiley: New York, 2002; Vol. II, p 2309; For recent reviews, see: (b)
Zimmer, R.; Dinesh, C. U.; Nandanan, E.; Khan, F. A. Chem. Rev. 2000, 100, 3067;
(c) Bates, R. W.; Satcharoen, V. Chem. Soc. Rev. 2002, 31, 12; (d) Ma, S. Acc. Chem.
Res. 2003, 36, 701; (e) Nakamura, I.; Yamamoto, Y. Chem. Rev. 2004, 104, 2127;
(f) Zeni, G.; Larock, R. C. Chem. Rev. 2004, 104, 2285; (g) Soderberg, B. C. G.
Coord. Chem. Rev. 2004, 248, 1085; (h) Vizer, S. A.; Yerzhanov, K. B.; Quntar, A. A.
A. A.; Dembitsky, V. M. Tetrahedron 2004, 60, 5499; (i) Muzart, J. Tetrahedron
2005, 61, 9423; (j) Asao, N. Synlett 2006, 1645; (k) Zeni, G.; Rarock, R. C. Chem.
Rev. 2006, 106, 4644.
6. (a) Marshall, J. A.; Robinson, E. D. J. Org. Chem. 1990, 55, 3450; (b) Marshall, J. A.;
Sehon, C. A. J. Org. Chem. 1995, 60, 5966; (c) Hashmi, A. S. K. Angew. Chem. 1995,
107, 1749; . Angew. Chem., Int. Ed. Engl. 1995, 34, 1581; (d) Hashmi, A. S. K.;
Ruppert, T. L.; Knöfel, T.; Bats, J. W. J. Org. Chem. 1997, 62, 7295; (e) Hashmi, A.
S. K.; Schwarz, L.; Choi, J.-H.; Frost, T. M. Angew. Chem. 2000, 112, 2382; . Angew.
Chem., Int. Ed. 2000, 39, 2285; (f) Ma, S.; Li, L. Org. Lett. 2000, 2, 941; (g) Ma, S.;
Zhang, J.; Lu, L. Chem. Eur. J. 2003, 9, 2447; (h) Ma, S.; Yu, Z. Chem. Eur. J. 2004,
10, 2078; (i) Ma, S.; Yu, Z.; Gu, Z. Chem. Eur. J. 2005, 11, 2351; (j) Deng, Y.; Li, J.;
Ma, S. Chem. Eur. J. 2008, 14, 4263; (k) Alcaide, B.; Almendros, P.; Martínez del
Campo, T. Eur. J. Org. Chem. 2007, 2844.
7. Propargyl acetates: (a) Kato, K.; Nouchi, H.; Ishikura, K.; Takaishi, S.; Motodate,
S.; Tanaka, H.; Okudaira, K.; Mochida, T.; Nishigaki, R.; Shigenobu, K.; Akita, H.
Tetrahedron 2006, 62, 2545; 4-Alkynols: (b) Kato, K.; Matsuba, C.; Kusakabe, T.;
Takayama, H.; Yamamura, S.; Mochida, T.; Akita, H.; Peganova, T. A.; Vologdin,
N. V.; Gusev, O. V. Tetrahedron 2006, 62, 9988; 4-Alkynones: (c) Kusakabe, T.;
Kato, K.; Takaishi, S.; Yamamura, S.; Mochida, T.; Akita, H.; Peganova, T. A.;
Vologdin, N. V.; Gusev, O. V. Tetrahedron 2008, 64, 319; Propargyl ketols: (d)
Kato, K.; Motodate, S.; Takaishi, S.; Kusakabe, T.; Akita, H. Tetrahedron 2008, 64,
4627; Intermolecular methoxycarbonylation: (e) Kato, K.; Motodate, S.;
Mochida, T.; Kobayashi, T.; Akita, H. Angew. Chem., Int. Ed. 2009, 48, 3326.
8. (a) Kato, K.; Teraguchi, R.; Yamamura, S.; Mochida, T.; Akita, H.; Peganova, T. A.;
Vologdin, N. V.; Gusev, O. V. Synlett 2007, 638; (b) Kato, K.; Teraguchi, R.;
Motodate, S.; Uchida, A.; Mochida, T.; Peganova, T. A.; Vologdin, N. V.; Akita, H.
Chem. Commun. 2008, 3687; (c) Kato, K.; Akita, H. J. Synth. Org. Chem. Jpn. 2009,
67, 16.
In conclusion, we have developed a new type of PdII-catalyzed
carbonylative dimerization of allenyl ketones 1. The difuranylke-
tones 4 were obtained in moderate to good yields. The electrophi-
licity of the acylpalladium species B is considered to contribute to
the oxypalladation of an additional molecule of 1. We are currently
investigating a new tandem reaction for the synthesis of other
kinds of diheteroaromatic ketones based on the cyclization–car-
bonylation–cyclization strategy presented here while also trying
to improve the synthetic efficiency of some tamoxifen analogues.
Supplementary data
Supplementary data associated with this article can be found, in
9. Fe(CO)5 catalyzed cyclization of 1,2-allenyl ketones with CO afforded lactones:
Sigman, M. S.; Kerr, C. E.; Eaton, B. E. J. Am. Chem. Soc. 1993, 115,
7545.
10. Synthesis of difuranylketones amd arylfuranylketones: (a) Benassi, R.; Folli, U.;
Larossi, D.; Schenetti, L.; Taddei, F.; Musatti, A.; Nardelli, M. J. Chem. Soc., Perkin
Trans. 2 1989, 1741; (b) Yang, Y.; Wong, H. N. C. Tetrahedron 1994, 50, 9583; (c)
Okuro, K.; Furuune, M.; Miura, M.; Nomura, M. J. Org. Chem. 1992, 57, 4754.
11. Marshall, J. A.; Yanik, M. M. Tetrahedron Lett. 2000, 41, 4717.
12. In addition, the use of (À)-sparteine/Pd(TFA)2 and (2,2’-bipyridine)
dichloropalladium(II) resulted in no reaction and complex mixture, respectively.
13. Xu, Y.-H.; Lu, J.; Loh, T.-P. J. Am. Chem. Soc 2009, 131, 1372.
14. Crystallographic data (excluding structure factors) for the structure have been
deposited with the Cambridge Crystallographic Data Center as supplementary
publication No. 723226. See the Supplementary data of this article.
References and notes
1. Yang, Y.; Wong, H. N. C. Tetrahedron 1994, 50, 9583. and references cited therein.
2. Neumann, H.; Brennführer, A.; Beller, M. Chem. Eur. J. 2008, 14, 3645. and
references cited therein.
3. (a) Nguyen, A.; Top, S.; Pigeon, P.; Vessières, A.; Hillard, E. A.; Plamont, M.-A.;
Huché, M.; Rigamonti, C.; Jaouen, G. Chem. Eur. J. 2009, 15, 684; (b) Chao, E. Y. H.;
Collins, J. L.; Gaillard, S.; Miller, A. B.; Wang, L.; Orband-Miller, L. A.; Nolte, R. T.;
McDonnell, D. P.; Willson, T. M.; Zuercher, W. J. Bioorg. Med. Chem. Lett. 2006, 16,
821;(c) Pandey, R. K.; Wakharkar, R. D.; Kumar, P. Synth. Commun. 2005, 35, 2795;
(d) Olier-Reuchet, C.; Aitken, D. J.; Bucourt, R.; Husson, H.-P. Tetrahedron Lett.
1995, 36, 8221; (e) Coe, P. L.; Scriven, C. E. J. Chem. Soc., Perkin Trans. 1 1986, 475.
4. (a) Schmidt, F.; Stemmler, R. T.; Rudolph, J.; Bolm, C. Chem. Soc. Rev. 2006, 35,
454; (b) Das, S. K.; Panda, G.; Chaturvedi, V.; Manju, Y. S.; Gaikwad, A. K.; Sinha,